Ellen Chiniara Kymera Therapeutics, Inc. (KYMR) insider trading activity

Ellen Chiniara is Chief Legal Officer of Kymera Therapeutics, Inc.. Currently has a direct ownership of 80,085 shares of KYMR, which is worth approximately $2.42 Million. The most recent transaction as insider was on Mar 03, 2025, when has been sold 2,241 shares (Common Stock) at a price of $30.67 per share, resulting in proceeds of $68,731. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 80.1K

43.11% 3M change

43.11% 12M change

Total Value Held $2.42 Million

Ellen Chiniara Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Mar 03 2025	SELL Open market or private sale	$68,731 $30.67 p/Share	2,241 Reduced 2.72%	80,085 Common Stock
Mar 03 2025	BUY Grant, award, or other acquisition	-	27,500 Added 25.04%	82,326 Common Stock
Jan 06 2025	SELL Open market or private sale	$130,635 $41.75 p/Share	3,129 Reduced 5.4%	54,826 Common Stock
Mar 01 2024	BUY Grant, award, or other acquisition	-	21,755 Added 27.99%	55,960 Common Stock
Jan 04 2024	SELL Open market or private sale	$74,401 $22.58 p/Share	3,295 Reduced 8.79%	34,205 Common Stock
Jan 03 2023	BUY Grant, award, or other acquisition	-	37,500 Added 50.0%	37,500 Common Stock

Also insider at

ALXN

ALEXION PHARMACEUTICALS, INC.

EVP & Chief Legal Officer

CMPX

Compass Therapeutics, Inc. Healthcare

Director

Ellen Chiniara

Chief Legal Officer

Boston, MA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells KYMR shares.

Notify only if

Value

Insider Trading

Get notified when an Kymera Therapeutics, Inc. insider buys or sells KYMR shares.

Notify only if

Operation

Value

Type

News

Receive news related to Kymera Therapeutics, Inc.

Track Activities on KYMR

Account